ALLIANCE PHARMA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 49.55 GBX | +4.32% |
|
+9.02% | +22.35% |
| 09-30 | EARNINGS: Alliance Pharma swings to profit; DG Innovate loss widens | AN |
| 09-30 | Alliance Pharma plc Provides Revenue Guidance for the Full Year 2024 | CI |
Main competitors
| Revenues ($) (Y-1) | Net margin (Y-1) | Operating Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Debt/EBITDA) (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 234M | -18.14% | +22.91% | +10.17% | +5.32% | 2.03x | ||
| 5.72B | +19.75% | +20.56% | +16.00% | +11.52% | -1.3x | ||
| 13.36B | +6.02% | +6.92% | +5.30% | +4.41% | -1.58x | ||
| 9.65B | +0.80% | +15.42% | +10.96% | +5.15% | 1.79x | ||
| 3.04B | +15.99% | +20.33% | +16.45% | +13.26% | -0.86x | ||
| 2.3B | +19.74% | +23.22% | +20.61% | +13.98% | -0.06x | ||
| 3.33B | +25.46% | +31.82% | +16.70% | +18.23% | -0.93x | ||
| 463M | +17.24% | +19.49% | +7.35% | +6.06% | -1.25x | ||
| 1.39B | -12.71% | +5.19% | -11.52% | - | -0.56x | ||
| 2.07B | +19.73% | +23.58% | +14.48% | +11.70% | -0.33x | ||
| 1.91B | +17.38% | +22.12% | +14.50% | +11.50% | -0.35x | ||
| 2.52B | +9.85% | +15.66% | +5.15% | +3.22% | 2.13x | ||
| 496M | +19.39% | +24.63% | +23.47% | +17.52% | -0.36x | ||
| 761M | +16.63% | +18.59% | +23.90% | +12.19% | - | ||
| 293M | +26.56% | +28.47% | +22.32% | +19.10% | -0.83x | ||
| 918M | +10.82% | +10.77% | +9.96% | +6.61% | -0.58x | ||
| 1.04B | +10.68% | +14.80% | +15.15% | +7.65% | 1.59x | ||
| Average | 2.91B | +12.07% | +19.09% | +13.00% | +10.46% | -0.09x | |
| Weighted average by Cap. | 5.98B | +13.43% | +17.53% | +12.81% | +9.78% | -0.62x |
- Stock Market
- Equities
- APH Stock
- Sector Alliance Pharma plc
- Financial comparisons
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition